Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
25 Results for "
Relative configuration
" in MedChemExpress (MCE) Product Catalog:
Products (25)
25 Results for "Relative configuration" in MCE Product Catalog:
1
1 Cited Publications
Cat. No.: HY-128838A
Purity: 98.18%
Target:
Research Areas:
(rel)-PROTAC ERRα Degrader-1 is a relative configuration of PROTAC ERRα Degrader-1. PROTAC ERRα Degrader-1 comprises a MDM2 ligand binding group, a linker and an estrogen-related receptor alpha (ERRa) binding group. PROTAC ERRα Degrader-1 is an estrogen-related receptor alpha (ERRa) degrader .
Category:
Monophenols Agrostidoideae Metabolic Disease Phenols Plants Disease Research Fields Triticum aestivum L.
Target:
Cat. No.: HY-160440
CAS No.: 2307718-96-1
Target:
Research Areas:
rel-VU6021625 is the relative configuration of VU6021625 (HY-160440A). VU6021625 is a potent and selective mAChR M4 antagonist with IC50 values of 0.44 nM and 57 nM for human M4, rat M4, respectively .
Cat. No.: HY-W337569
CAS No.: 188416-29-7
Synonyms: (±)-UK-109496
(±)-Voriconazole ((±)-UK-109496) is a relative configuration of Voriconazole (HY-76200). Voriconazole is an antifungal agent .
Cat. No.: HY-114324A
Purity: 98.99%
rel-PROTAC PARP1 degrader is the relative configuration of ROTAC PARP1 degrader (HY-114324). PROTAC PARP1 degrader is a PROTAC PARP1 degrader. PROTAC PARP1 degrader mediates the interaction between PARP1 and MDM2 E3 ubiquitin ligase, thereby inducing ubiquitination of PARP1 and subsequent proteasome-mediated degradation. PROTAC PARP1 degrader selectively inhibits the growth of breast cancer cells. PROTAC PARP1 degrader induces cell apoptosis by activating caspase-3 and phosphatidylserine externalization. PROTAC PARP1 degrader can be used in the research of triple-negative breast cancer .
Cat. No.: HY-122359A
CAS No.: 31477-60-8
Synonyms: rel-L-Centchroman; Ormeloxifene
Research Areas:
rel-Levormeloxifene (rel-L-Centchroman) is the relative configuration of Levormeloxifene (HY-122359). rel-Levormeloxifene is a selective estrogen receptor modulator (SERM). rel-Levormeloxifene inhibits proliferation of leukemia cells with IC50 about 7 μM, arrests cell cycle at G0/G1 phase, and induces apoptosis. rel-Levormeloxifene induces differentation of myelogenesis leukemia, and enhances ROS production in K562 cells .
Cat. No.: HY-113068R
CAS No.: 148-03-8
Target:
Cat. No.: HY-109092A
CAS No.: 2730989-98-5
Synonyms: rel-LIK066
Target:
Research Areas:
rel-Licogliflozin is a relative configuration of Licogliflozin (HY-109092). Licogliflozin is a sodium glucose cotransporter (SGLT1 and SGLT2) inhibitor .
Cat. No.: HY-N15739
CAS No.: 2649683-40-7
Target:
Category:
Natural Products Leguminosae Labiatae Erythrina poeppigiana Plants Glycyrrhiza uralensis Fisch.
Target:
Cat. No.: HY-13607A
CAS No.: 573738-99-5
Target:
Research Areas:
(rel)-BMS-641988 is a relative configuration of BMS-641988. BMS-641988 is a potent nonsteroidal androgen receptor antagonist. BMS-641988 has the potential for the research of prostate cancer .
Cat. No.: HY-117283
CAS No.: 89544-10-5
Synonyms: rel-RP 52891
Target:
Research Areas:
rel-Aprikalim (rel-RP 52891) is the relative configuration of Aprikalim (HY-121183). Aprikalim (RP 52891), a potassium channel opener (KCO), activates ATP-sensitive K + (KATP) channels in guinea pig ventricular myocytes .
Cat. No.: HY-103451A
CAS No.: 138090-06-9
Target:
Research Areas:
rel-(R,R)-THC is the relative configuration of (R,R)-THC (HY-103451). (R,R)-THC is an ERα agonist and an ERβ antagonist, with Kis of 9.0 nM and 3.6 nM for ERα and ERβ, respectively. (R,R)-THC has higher relative binding affinity for ERβ than ERα with the values of 25 and 3.6 .
Cat. No.: HY-N12207
CAS No.: 918784-99-3
Category:
Target:
Cat. No.: HY-18941B
CAS No.: 176027-90-0
Synonyms: (rel)-LY354740; (rel)-Eglumetad
Target:
Research Areas:
(rel)-Eglumegad ((rel)-LY354740) is a relative configuration of Eglumegad (HY-18941). Eglumegad is a highly potent and selective group II (mGlu2/3) receptor agonist with EC50s of 5 and 24 nM for transfected human mGlu2 and mGlu3 receptors, respectively .
Cat. No.: HY-101512D
CAS No.: 2747996-65-0
Target:
Research Areas:
rel-A-395 hydrochloride is the relative configuration of A-395 (HY-101512) hydrochloride. A-395 is an antagonist of polycomb repressive complex 2 (PRC2) protein-protein interactions that potently inhibits the trimeric PRC2 complex (EZH2-EED-SUZ12) with an IC50 of 18 nM .
Cat. No.: HY-100449A
CAS No.: 1224444-55-6
Target:
Research Areas:
(S)-AL 8810 is an 11β-fluoro analog of PGF2α that acts as a potent and selective antagonist at the FP receptor. (S)-AL 8810 is the C-15 epimer of AL 8810, having the
inverse, (S), or "natural" configuration at C-15 relative to AL 8810, which is 15-(R) .
Cat. No.: HY-90001S3
CAS No.: 1217720-20-1
Synonyms: rel-ABT 538-d6; rel-RTV-d6
Cat. No.: HY-10121D
CAS No.: 1261398-77-9
Synonyms: rel-Org 5222 hydrochloride
Research Areas:
rel-Asenapine (rel-Org 5222) hydrochloride is a relative configuration of Asenapine hydrochloride (HY-16567). Asenapine (Org 5222) hydrochloride, an atypical antipsychotic, is an antagonist of serotonin receptors (pKi: 8.4-10.5), adrenoceptors (pKi: 8.9-9.5), dopamine receptors (pKi: 8.9-9.4) and histamine receptors (pKi: 8.2-9.0). Asenapine hydrochloride can be used in the research of schizophrenia and bipolar disorder .
- 1
- 2
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
